Navigation Links
Entries Still Open for US Clinical Researcher of the Year 2012 Competition
Date:7/31/2012

LONDON, July 31, 2012 /PRNewswire/ --

There is still time to enter the US Clinical Researcher of the Year competition, whose theme this year focuses on using resources more effectively without compromising patient safety or quality of data.

The competition welcomes participants from the following areas of research:

  • Study Nurse/Clinical Research Coordinator
  • Clinical Research Associates (with varying levels of experience)
  • Project Manager working within a CRO environment
  • Study Leader working within a pharma/sponsor environment
  • Clinical Trial Teams

Entries are building fast with engagement from a broad cross-section of CRO and pharma competitors including: PRA, PPD, Parexel, Chiltern, INC Research, Shire Pharmaceuticals, GSK, Sanofi, Benchmark Research, Endo Pharmaceuticals, MSD, Abbott and Allergan.

Professionals within the clinical research fraternity are able to compete on a level playing field in this competition, working through a series of competency-based exercises that start with a multiple-choice questionnaire based on ICH/GCP and end with a case-study devised to explore different approaches to risk-based or targeted monitoring.

Organised by media company PharmaTimes, the competition is independently judged by a high level Executive Steering Committee drawn from senior pharma clinical leaders within AZ, GSK, MSD, Sanofi, Shire, Endo Pharma, Allergan, Alcon and Stiefel.

Finals day and presentation of the US Clinical Researcher of the Year awards will take place on 8 November and will be hosted by competition sponsors, SAS, at their Executive Briefing Centre in Cary, North Carolina.

Closing date for entry to the competition is 7 September. For more information and/or to enter the competition please go to http://www.usclinicalresearcher.com.

Contacts: Sean Morgan-Jones - +44(0)208-8788566 - email: sean@pharmatimes.com.



'/>"/>
SOURCE Pharma Times
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Call for Entries: International Bureau for Epilepsy and UCB launch the 2012 Excellence in Epilepsy Journalism Award to recognize exceptional reporting on epilepsy
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
3. Disability Advocates Tell Medicare: Use a Clinical Template to Accurately Document Medical Need for Wheelchairs
4. Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
5. PRA Participates in Landmark Alzheimers Prevention Clinical Trial
6. Rheumatoid Arthritis New Major Clinical Target After Mesoblast Obtains Positive Results in Inflammatory Arthritis
7. Chimerixs Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study
8. Berg Pharma launches clinical trial on BPM 31543 for prevention of chemotherapy-induced alopecia (CIA)
9. Caspase Inhibitor Enters Clinical Trial In Islet Transplantation As Treatment For Diabetes
10. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
11. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... 2016  Results from the Phase II SUSTAIN study ... reduced the median annual rate of sickle cell-related pain ... 2.98, p=0.010) in patients with or without hydroxyurea therapy ... being featured in the official press briefing at the ... Meeting and presented during the Plenary Scientific Session tomorrow ...
(Date:12/2/2016)... December 2, 2016 - bioLytical lanza el INSTI HIV ... la OMS     Continue Reading ... ... , , bioLytical ... anunciado hoy que está expandiendo el lanzamiento de su INSTI HIV Self Test ...
(Date:12/2/2016)... December 2, 2016 According to the ... Market Study on Automated Endoscope Reprocessors: Single Basin Automated Endoscope ... 8.6% Between 2016 and 2024 " the global automated endoscope reprocessors market was ... to expand at a CAGR of 7.2% during an eight-year ... 1,367.6 Mn by 2024. ...
Breaking Medicine Technology:
(Date:12/4/2016)... , ... December 03, 2016 , ... While James Earl ... serving as host for in a show called "Front Page". One of the forthcoming ... years, breast cancer rates have plummeted in large part due to early detection. Like ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to ... advantage of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser ... of age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... will speak at the American Conference Institute’s 21st Drug & Medical Device Litigation ... Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 business, civic, ... to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, ... and operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, ...
(Date:12/2/2016)... ... , ... The annual time frame to change Medicare health and prescription drug ... 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan to ... make changes during this period order for their new policy to go into effect ...
Breaking Medicine News(10 mins):